Inventor · disambiguated record
Wilfried Schwab
Also filed as: SCHWAB WILFRIED
46 granted patents·8 pending applications·653 citations·filing 1983–2024
98Inventor score
Files withHOECHST AG13AVENTIS PHARMA GMBH12AICURIS ANTI INFECTIVE CURES GMBH9AICURIS GMBH & CO KG6GPC BIOTECH AG2
Top patents by PatentIndex Score
54 records- 0194US5314863AIsoxazolines, their preparation, and their use as plant-protecting agentsHOECHST AG·Filed 1990·Granted May 24, 1994·92 cites·11 claims
- 0293US9119786B2Crystalline N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mono mesylate monohydrate having a specific particle size distribution range and a specific surface area range for use in pharmaceutical formulationsAICURIS GMBH & CO KG·Filed 2013·Granted Sep 1, 2015·15 cites·19 claims
- 0393US4667028AProcess for the preparation of cephem compoundsHOECHST AG·Filed 1984·Granted May 19, 1987·39 cites·2 claims
- 0492US10137117B2Crystalline N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2[4-(2-pyridinyl)phenyl]acetamide mono mesylate monohydrate having a specific particle size distribution range and a specific surface area range for use in pharmaceutical formulationsAICURIS ANTI INFECTIVE CURES GMBH·Filed 2017·Granted Nov 27, 2018·6 cites·22 claims
- 0592US9592225B2Crystalline N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mono mesylate monohydrate having a specific particle size distribution range and a specific surface area range for use in pharmaceutical formulationsAICURIS ANTI-INFECTIVE CURES GMBH·Filed 2015·Granted Mar 14, 2017·8 cites·22 claims
- 0691US9889124B2Crystalline N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mono mesylate monohydrate having a specific particle size distribution range and a specific surface area range for use in pharmaceutical formulationsAICURIS ANTI INFECTIVE CURES GMBH·Filed 2015·Granted Feb 13, 2018·6 cites·30 claims
- 0790US4647556ACephalosporin derivativesHOECHST AG·Filed 1983·Granted Mar 3, 1987·43 cites·3 claims
- 0889US6265588B1Isoxazole and crotonamide derivatives and their use as pharmaceuticals and diagnosticsAVENTIS PHARMA GMBH·Filed 2000·Granted Jul 24, 2001·34 cites·8 claims
- 0988US11021474B2N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)-phenyl]-acetamide free base hemihydrate, methods of manufacture and uses thereofAICURIS ANTI INFECTIVE CURES GMBH·Filed 2017·Granted Jun 1, 2021·4 cites·11 claims
- 1088US8084457B2Pharmaceutically active 4,6-disubstituted aminopyrimidine derivatives as modulators of protein kinasesCHOIDAS AXEL·Filed 2004·Granted Dec 27, 2011·76 cites·25 claims
- 1187US6159995ASubstituted diaminocarboxylic acidsAVENTIS PHARMA GMBH·Filed 1998·Granted Dec 12, 2000·72 cites·13 claims
- 1286US12070451B2Sulfate salt of the free base of n-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-n-methyl-2-[4-(2-pyridinyl)-phenyl]-acetamide, pharmaceutical formulations, methods of manufacture and uses thereofAICURIS GMBH & CO KG·Filed 2022·Granted Aug 27, 2024·1 cites·12 claims
- 1385US9637459B2Sodium and calcium salts of dihydroquinazoline derivative and use thereof as antiviral agentsAICURIS GMBH & CO KG·Filed 2013·Granted May 2, 2017·4 cites·20 claims
- 1483US11266636B2Maleate salt of the free base of N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)-phenyl]-acetamide, pharmaceutical formulations, methods of manufacture and uses thereof for the treatment of herpes virusesAICURIS ANTI INFECTIVE CURES GMBH·Filed 2017·Granted Mar 8, 2022·2 cites·15 claims
- 1582US6573277B2Cyclic and heterocyclic N-substituted α-iminohydroxamic and -carboxylic acidsFiled 2001·Granted Jun 3, 2003·15 cites·11 claims
- 1680US9340535B2N-[5-(Aminosulfony1)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mesylate monohydrateAICURIS GMBH & CO KG·Filed 2012·Granted May 17, 2016·5 cites·25 claims
- 1780US6815440B2Cyclic and heterocyclic N-substituted α-iminohydroxamic and -carboxylic acidsAVENTIS PHARMA GMBH·Filed 2003·Granted Nov 9, 2004·12 cites·19 claims
- 1879US6451824B1Sulfonylaminocarboxylic acidsAVENTIS PHARMA GMBH·Filed 1998·Granted Sep 17, 2002·37 cites·14 claims
- 1979US6335333B1N-arylsulfonylamino acid omega-amidesAVENTIS PHARMA GMBH·Filed 2000·Granted Jan 1, 2002·11 cites·4 claims
- 2078US2025042893A1N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)-phenyl]-acetamide free base hemihydrate, methods of manufacture and uses thereofAICURIS ANTI INFECTIVE CURES GMBH·Filed 2024·Application pending·0 cites
- 2177US2024350468A1Maleate salt of the free base of n-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-n-methyl-2-[4-(2-pyridinyl)-phenyl]-acetamide, pharmaceutical formulations, methods of manufacture and uses thereofAICURIS GMBH & CO KG·Filed 2024·Application pending·0 cites
- 2275US5814627A3, 5-disubstituted and 3, 4, 5-trisubstituted 2-isoxazolines and isoxazoles, process for their preparation and their use as pharmaceuticalsHOECHST AG·Filed 1995·Granted Sep 29, 1998·40 cites·12 claims
- 2373US8507498B24, 6-disubstituted aminopyrimidine derivatives as inhibitors of protein kinasesWABNITZ PHILIPP·Filed 2008·Granted Aug 13, 2013·4 cites·24 claims
- 2472USRE49697ECrystalline N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mono mesylate monohydrate having a specific particle size distribution range and a specific surface area range for use in pharmaceutical formulationsAICURIS ANTI INFECTIVE CURES GMBH·Filed 2020·Granted Oct 17, 2023·0 cites·32 claims
- 2571US6894184B2Process for preparing 2-cyano-3-hydroxy-N-(phenyl)but-2-enamidesAVENTIS PHARMA GMBH·Filed 2004·Granted May 17, 2005·6 cites·9 claims
- 2671US6355673B1Substituted diaminocarboxylic acidsAVENTIS PHARMA GMBH·Filed 2000·Granted Mar 12, 2002·5 cites·15 claims
- 2771US6207672B1Cyclic and heterocyclic N-substituted α-iminohydroxamic and carboxyclic acidsAVENTIS PHARMA GMBH·Filed 1996·Granted Mar 27, 2001·25 cites·12 claims
- 2870US12152022B2N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)-phenyl]-acetamide free base hemihydrate, methods of manufacture and uses thereofAICURIS ANTI INFECTIVE CURES GMBH·Filed 2021·Granted Nov 26, 2024·0 cites·24 claims
- 2969US10442773B2Amorphous letermovir and solid pharmaceutical formulations thereof for oral administrationAICURIS ANTI INFECTIVE CURES GMBH·Filed 2014·Granted Oct 15, 2019·1 cites·18 claims
- 3069US5273989A3,5-disubstituted 2-isoxazolines and isoxazoles, agents containing them and their useHOECHST AG·Filed 1991·Granted Dec 28, 1993·29 cites·19 claims
- 3168US4692516AProcess for the manufacture of 3-pyridinium-methyl-cephalosporinsHOECHST AG·Filed 1984·Granted Sep 8, 1987·7 cites·2 claims
- 3254US5977151AIsoxazole and crotonamide derivatives and their use as pharmaceuticals and diagnosticsHOECHST AG·Filed 1998·Granted Nov 2, 1999·9 cites·10 claims
- 3354US5006515APharmaceuticals, phosphorus-containing 2-isoxazolines and isoxazoles contained thereinHOECHST AG·Filed 1988·Granted Apr 9, 1991·7 cites·11 claims
- 3451US7160903B2Sulfonylaminocarboxylic acidsSANOFI AVENTIS DEUTSCHLAND·Filed 2002·Granted Jan 9, 2007·0 cites·10 claims
- 3550US6500811B2Sulfonylaminophosphinic and sulfonylaminophosphonic acid derivatives, methods for their preparation and useAVENTIS PHARMA GMBH·Filed 2001·Granted Dec 31, 2002·0 cites·24 claims
- 3650US6201130B1N-arylsulfonylamino acid omega-amidesAVENTIS PHARMA DUETSCHLAND GMB·Filed 1999·Granted Mar 13, 2001·10 cites·6 claims
- 3750US6121479AIsoxazole and crotonamide derivatives and their use as pharmaceuticals and diagnosticsHOECHST AG·Filed 1999·Granted Sep 19, 2000·7 cites·8 claims
- 3848US6387934B12-Cyano-3,5-dihydroxyhex-2-enecarboxamide derivativesAVENTIS PHARMA GMBH·Filed 2000·Granted May 14, 2002·0 cites·19 claims
- 3947US5886033AUse of isoxazole and crotonamide derivatives for the treatment of carcinomatous disordersHOECHST AG·Filed 1996·Granted Mar 23, 1999·11 cites·11 claims
- 4045US10603384B2Pharmaceutical composition containing an antivirally active dihydroquinazoline derivativeAICURIS GMBH & CO KG·Filed 2013·Granted Mar 31, 2020·0 cites·44 claims
- 4144US6235727B1Sulfonylaminophosphinic and sulfonylaminophosphinic acid derivatives, methods for their preparation and useAVENTIS PHARMA GMBH·Filed 1999·Granted May 22, 2001·4 cites·22 claims
- 4243US2013338147A14,6-disubstituted aminopyrimidine derivatives as inhibitors of protein kinasesINGENIUM PHARMACEUTICALS GMBH·Filed 2013·Application pending·0 cites
- 4341US2018127681A1Glycosylated aroma- and fragrance precursors and fragrance products that can be activatedUNIV MUENCHEN TECH·Filed 2016·Application pending·0 cites
- 4440US7161008B2Optically active β-aminoketones, optically active 1,3-amino alcohols and processes for preparing themSANOFI AVENTIS DEUTSCHLAND·Filed 2003·Granted Jan 9, 2007·0 cites·13 claims
- 4539US2017204380A1Glycosyl transferases and their usesUNIV MUENCHEN TECH·Filed 2015·Application pending·0 cites
- 4638US2008194574A1Pyrazine Derivatives As Effective Compounds Against Infectious DiseasesAXXIMA PHARMACEUTICALS AG·Filed 2004·Application pending·0 cites
- 4738US2008207677A1Napthyridine Compounds As Rock InhibitorsGPC BIOTECH AG·Filed 2006·Application pending·0 cites
- 4837US6020372AUse of isoxazole and crotonamide derivatives for the treatment of carcinomatous disordersHOECHST AG·Filed 1998·Granted Feb 1, 2000·4 cites·4 claims
- 4937US2007275962A1Heterobicyclic Compounds as Pharmaceutically Active AgentsGPC BIOTECH AG·Filed 2004·Application pending·0 cites
- 5036US9133165B2Sulfonic acid salts of heterocyclylamide-substituted imidazolesSCHWAB WILFRIED·Filed 2012·Granted Sep 15, 2015·0 cites·20 claims
Showing the top 50 of 54 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Wilfried Schwab files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →